Back to Evidence Hub
Case Study scg-with-your-phone-diagnosis-of-rhythmic-spectrum-disorders-in-field-conditions
2026 Release

SCG With Your Phone: Diagnosis of Rhythmic Spectrum Disorders in Field Conditions

Executive Summary

This study introduces a robust deep-learning framework based on a modified U-Net v3 architecture for seismocardiography (SCG) signal segmentation and rhythm analysis using consumer smartphones. The framework incorporates multi-scale convolutions, residual connections, and attention gates to handle noisy, real-world data, achieving state-of-the-art performance with sensitivity of 99.80% and PPV of 99.09%. The findings demonstrate the feasibility of low-cost, automated cardiac monitoring in field conditions, paving the way for scalable cardiovascular assessment and multimodal diagnostic systems.

This study shows that smartphones can reliably monitor heart rhythms using vibrations from the chest, thanks to advanced AI that works even in noisy, real-world conditions.

Answer Machine Insights

Q: What is the primary innovation in the proposed SCG analysis method?

The primary innovation is the modified U-Net v3 architecture, which integrates multi-scale convolutions, residual connections, and attention gates for robust SCG segmentation in noisy, real-world conditions.

To address the shortcomings of the baseline U-Net, we introduced three key modifications that resulted in the U-Net v3 architecture (Figure 3), tailored specifically for SCG segmentation.

Q: How does the model handle variability in smartphone orientation?

The model uses an adaptive 3D-to-1D projection pipeline to estimate the optimal viewing direction for SCG signals, ensuring orientation-agnostic performance.

To achieve orientation-agnostic performance, we developed an adaptive 3D-to-1D projection pipeline that estimates the optimal viewing direction n ∈R3 – the unit vector aligned with cardiac-induced chest displacement – using only the raw triaxial signal.

Key Results

  • The U-Net v3 architecture achieved a segmentation Dice score of 96.47% and sensitivity of 99.80%.

  • The proposed method demonstrated 94% satisfactory ratings in real-world, unlabeled data evaluations by cardiologists.

Visual Evidence

Figure 2: Labeled SCG.

Figure 2: Labeled SCG.